Transactivation Function-2 of Estrogen Receptor α Contains Transactivation Function-1-regulating Element.

作者: Yukitomo Arao , Laurel A. Coons , William J. Zuercher , Kenneth S. Korach

DOI: 10.1074/JBC.M115.638650

关键词:

摘要: ERα has a ligand-dependent transactivation function in the ligand binding domain of C terminus (AF-2) and ligand-independent activation N (AF-1). It is still not fully understood how AF-1 AF-2 activities are regulated cooperatively by ligands. To evaluate involvement estrogenic various compounds, we analyzed these functions using AF-1-truncated AF-2-mutated mutants. composed two domains with flexible static regions. We used an region mutant mutant. Both mutants have been reported as non-E2 responsive due to disruption E2-mediated coactivator recruitment AF-2. The were activated agonists, but surprisingly antagonists selective estrogen receptor modulators (SERMs) This antagonist reversal activity was derived from AF-1. Furthermore, demonstrated that contains suppression C-terminal-truncated From findings hypothesized mutation disrupted its ability suppress AF-1, causing reversal. assess AF-2-mediated suppression, transcription physically separated novel hybrid reporter assay. observed suppressed SERMs did induce AF-1-mediated AF-2, which differed intact protein. These results imply SERM dependent on conformational change full-length molecule, allows for activation. Background: mechanism mediated N-terminal (AF-1) regulation unclear. Results: Disruption C-terminal resulted AF-1-dependent agonists. Conclusions: repression activity. Significance: may explain partial agonist/antagonist selected modulators.

参考文章(30)
Ho Yi Mak, Sue Hoare, Pirkko M. A. Henttu, Malcolm G. Parker, Molecular Determinants of the Estrogen Receptor-Coactivator Interface Molecular and Cellular Biology. ,vol. 19, pp. 3895- 3903 ,(1999) , 10.1128/MCB.19.5.3895
J. W. Zapf, A. De Los Reyes, H. Liu, Virgil Craig Jordan, E. S. Lee, Silencing and Reactivation of the Selective Estrogen Receptor Modulator-Estrogen Receptor α Complex Cancer Research. ,vol. 61, pp. 3632- 3639 ,(2001)
Silvia I. Anghel, Véronique Perly, Geneviève Melançon, Annie Barsalou, Samuel Chagnon, Angelika Rosenauer, Wilson H. Miller, Sylvie Mader, Aspartate 351 of estrogen receptor alpha is not crucial for the antagonist activity of antiestrogens. Journal of Biological Chemistry. ,vol. 275, pp. 20867- 20872 ,(2000) , 10.1074/JBC.M002098200
Guila Dayan, Mathieu Lupien, Anick Auger, Silvia I. Anghel, Walter Rocha, Sébastien Croisetière, John A. Katzenellenbogen, Sylvie Mader, Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha. Molecular Pharmacology. ,vol. 70, pp. 579- 588 ,(2006) , 10.1124/MOL.105.021931
Kyungsil Yoon, Lea Pallaroni, Matthew Stoner, Kevin Gaido, Stephen Safe, Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 78, pp. 25- 32 ,(2001) , 10.1016/S0960-0760(01)00070-X
Wilbert Zwart, Alexander Griekspoor, Valeria Berno, Kim Lakeman, Kees Jalink, Michael Mancini, Jacques Neefjes, Rob Michalides, PKA-induced resistance to tamoxifen is associated with an altered orientation of ERα towards co-activator SRC-1 The EMBO Journal. ,vol. 26, pp. 3534- 3544 ,(2007) , 10.1038/SJ.EMBOJ.7601791
William Bourguet, Pierre Germain, Hinrich Gronemeyer, Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications Trends in Pharmacological Sciences. ,vol. 21, pp. 381- 388 ,(2000) , 10.1016/S0165-6147(00)01548-0
Chris L. Waller, Tudor I. Oprea, Kun Chae, Hee-Kyoung Park, Kenneth S. Korach, Susan C. Laws, Thomas E. Wiese, William R. Kelce, L. Earl Gray, Ligand-based identification of environmental estrogens Chemical Research in Toxicology. ,vol. 9, pp. 1240- 1248 ,(1996) , 10.1021/TX960054F
D P McDonnell, D L Clemm, T Hermann, M E Goldman, J W Pike, Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Molecular Endocrinology. ,vol. 9, pp. 659- 669 ,(1995) , 10.1210/MEND.9.6.8592512